This session will highlight lessons learned from the recent FTA drug and alcohol program audit of nine FDOT sub-recipient agencies and will provide updates on topics such as oral fluid testing, the potential reclassification of marijuana, the addition of fentanyl to the DOT testing panel, and more. The session will conclude with the ever-popular “state of the state” - an analysis of the drug testing data from 2025.
Tuesday June 9, 2026 10:00am - 11:45am EDT Magnolia Room
